Johnson & Johnson (JNJ)

131.00
0.27 0.21
NYSE : Health Technology
Prev Close 131.27
Open 131.03
Day Low/High 130.14 / 131.36
52 Wk Low/High 121.00 / 148.99
Volume 4.19M
Avg Volume 7.65M
Exchange NYSE
Shares Outstanding 2.63B
Market Cap 345.70B
EPS 5.70
P/E Ratio 25.02
Div & Yield 3.80 (2.80%)
Kevin O'Leary's 'Wonderful' World of ETFs: 3 Great Ways to Follow the Shark

Kevin O'Leary's 'Wonderful' World of ETFs: 3 Great Ways to Follow the Shark

These funds from the Shark Tank star's O'Shares series focus on small-cap dividend names, internet giants and large-cap dividend U.S. dividend stocks.

Rewind: Why Jim Cramer Is Bullish on Johnson & Johnson Shares

Rewind: Why Jim Cramer Is Bullish on Johnson & Johnson Shares

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer is bullish on Johnson & Johnson shares.

Jim Cramer: A Pretty Wild Rally In Three Oppositional Groups

Jim Cramer: A Pretty Wild Rally In Three Oppositional Groups

How can this be? Let's take a look at the camps so we can figure it out.

Jim Cramer on Johnson & Johnson's Pharmaceuticals Sales Growth

Jim Cramer on Johnson & Johnson's Pharmaceuticals Sales Growth

When investors review a drug company, pay close attention to its pharma performance, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Jim Cramer on Netflix, Goldman Sachs, Bank of America and Johnson & Johnson

Jim Cramer on Netflix, Goldman Sachs, Bank of America and Johnson & Johnson

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending stocks from the floor of the New York Stock Exchange.

Highs (and Lows) of FANG Trading: Market Recon

Highs (and Lows) of FANG Trading: Market Recon

My Netflix short was a big winner yesterday, but I am also long Amazon and Google, which were hit with pretty strong collateral damage.

Bank Leadership Is Covering Up Some Ugly Market Issues

Bank Leadership Is Covering Up Some Ugly Market Issues

This quarter Netflix is not going to be the star of earnings season.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The major U.S. indices rose on Friday, closing out the week on a two-day winning streak.

Jim Cramer: This Market Isn't Done Going Higher

Jim Cramer: This Market Isn't Done Going Higher

We aren't done moving higher even with the president ready to strike at a moment's notice against any of our allies.

Stocks Rise Modestly and 4 Other Stories to Watch Premarket Friday

Stocks Rise Modestly and 4 Other Stories to Watch Premarket Friday

Happy Friday the 13th! These are the stories moving the market ahead of today's opening bell.

REPLAY: Jim Cramer on Broadcom, CA, Johnson & Johnson, Citigroup & Canopy Growth

REPLAY: Jim Cramer on Broadcom, CA, Johnson & Johnson, Citigroup & Canopy Growth

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's trending stocks from the floor of the New York Stock Exchange

Jim Cramer: This Market Is Not as Expensive as It Looks

Jim Cramer: This Market Is Not as Expensive as It Looks

The only way the market is "dangerously elevated" is if you believe that 2019 is going to be a horrendous year.

Crowning Achievement: Six Dividend Kings With 50+ Years of Rising Dividends

Crowning Achievement: Six Dividend Kings With 50+ Years of Rising Dividends

These 'recession-resistant' names have proven they can thrive in a variety of economic conditions and through changing technologies and sentiments.

The Charts and Indicators on Johnson & Johnson Are Still Mostly Bearish

The Charts and Indicators on Johnson & Johnson Are Still Mostly Bearish

Johnson & Johnson is among the companies that Jim Cramer has put on his new GLOOM index.

Jim Cramer: A GLUM Index For Gloomy Markets

Jim Cramer: A GLUM Index For Gloomy Markets

Taking the measure of what's keeping the markets in the dumps.

Tesla, Boeing and Merck Among Companies Hurt by Latest Tariffs

Tesla, Boeing and Merck Among Companies Hurt by Latest Tariffs

The latest announcement from the U.S. Trade Representative's office is chilling reading for free trade supporters.

Latest Reasons to Avoid Alzheimer's Plays

Latest Reasons to Avoid Alzheimer's Plays

Eli Lilly, AstraZeneca and vTv Therapeutics show why it's best to stay away from biotech's black hole.

Jim Cramer: Tech Can't Do it All Alone

Jim Cramer: Tech Can't Do it All Alone

Tech and retail gains aren't enough to lead markets to new highs.

Intermediate Trade: Johnson & Johnson

Intermediate Trade: Johnson & Johnson

JNJ is one of the best of breed of the pharmaceuticals sector.

Knowledge Is Power in Buy & Sell Decisions

Knowledge Is Power in Buy & Sell Decisions

Johnson & Johnson is a premiere company, but the trick is knowing when to buy it.

How to Play the Long Side of Johnson & Johnson

How to Play the Long Side of Johnson & Johnson

Shares of the healthcare giant pick up a quant rating upgrade as the charts suggest gains ahead.

2 Trading Opportunities in Health Care

2 Trading Opportunities in Health Care

The potential of these setups on the weekly chart is rather good.

Checked the 52-Week Low List Lately? It's a Graveyard of Well-Known Stocks

Checked the 52-Week Low List Lately? It's a Graveyard of Well-Known Stocks

What's really surprising is the emergence of so many household names on the list.

Jim Cramer: Reports of FANG's Death Greatly Exaggerated

Jim Cramer: Reports of FANG's Death Greatly Exaggerated

The big story is about cloud adoption.

Where (and How) to Find 'Dividend Aristocrats'

Where (and How) to Find 'Dividend Aristocrats'

The Nasdaq U.S. Broad Dividend Achievers Index is a good place to start.

Jim Cramer: Markets Seek Domestic Tranquility

Jim Cramer: Markets Seek Domestic Tranquility

Stock markets ran higher as investors turned towards domestic-focused companies.

60 Seconds: Own Dividend Stocks And Get Paid While The Market Tanks (Video)

60 Seconds: Own Dividend Stocks And Get Paid While The Market Tanks (Video)

It's hard to watch the market fall. But knowing you're still getting paid while it happens can make it much more palpable. That's why you need to have some dividend-producing stocks in your portfolio. Watch our video to find out why!

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

Markets were able to close the day in the green after a volatile day of trading.

Jim Cramer: Will the Techs Be Challenged, Too?

Jim Cramer: Will the Techs Be Challenged, Too?

The theft of intellectual property can be confronted by a Section 301 challenge directly from the trade representative.

An Updated Technical Strategy on Johnson & Johnson

An Updated Technical Strategy on Johnson & Johnson

Let's check and see how things are going.